EUVIMEDEUVIMED entdecken
Open Access

Apolipoprotein B in cardiovascular risk assessment

Maud Ahmad, Allan D Sniderman, Robert A Hegele

Canadian Medical Association Journal · 2023

DOI: 10.1503/cmaj.230048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Medical Association Journal, 2023. Verfasst von Maud Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Schulich School of Medicine and Dentistry (Ahmad, Hegele), Western University, London, Ont.; Mike and Valeria Rosenbloom Centre for Cardiovascular Pr…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cardiovascular System. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesCardiovascular SystemHumansRisk FactorsHeartApolipoproteins

Substanzen

Apolipoproteins

Autor:innen und Institutionen

  • Schulich School of Medicine and Dentistry (Ahmad, Hegele), Western University, London, Ont.; Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine (Sniderman), McGill University Health…

Zitieren

APA

Ahmad, M., Sniderman, A. D., & Hegele, R. A. (2023). Apolipoprotein B in cardiovascular risk assessment. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.230048

Vancouver

Ahmad M, Sniderman AD, Hegele RA. Apolipoprotein B in cardiovascular risk assessment. Canadian Medical Association Journal. 2023. doi:10.1503/cmaj.230048

BibTeX
@article{Ahmad2023,
  author = {Ahmad, Maud and Sniderman, Allan D and Hegele, Robert A},
  title = {Apolipoprotein B in cardiovascular risk assessment},
  journal = {Canadian Medical Association Journal},
  year = {2023},
  doi = {10.1503/cmaj.230048}
}
Kostenlos starten →